Zim Laboratories Quarterly Results for Trading Insights
Latest Quarter Net Profit
₹0 Cr
QSept 2025
In Sept 2025, Zim Laboratories (ZIMLAB) reported revenue ₹91 Cr and net profit ₹0 Cr — revenue -3.2% YoY. For annual financials, live price and key ratios, visit ZIMLAB share price.
ZIMLAB Quarterly Results — Revenue, Profit & EPS Highlights
Zim Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View Zim Laboratories yearly highs lows for the annual high/low range and current price position.
- Revenue of ₹91 Cr in Sept 2025 (-17.3% vs Mar 2025, -3.2% vs Sept 2024)
- EBITDA of ₹8 Cr in Sept 2025 (-50.0% vs Mar 2025)
- Operating Margin of 6.0% in Sept 2025 (-7.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.09 in Sept 2025 (-108.9% vs Mar 2025)
Zim Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS
ZIMLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 91 | 110 | 73 | 110 | 94 | -17.3% | -3.2% |
| Net Profit (₹ Cr) | 0 | 5 | -2 | 4 | 2 | - | - |
| EBITDA (₹ Cr) | 8 | 16 | 6 | 15 | 11 | - | - |
| EPS (₹) | -0.09 | 1.01 | -0.38 | 0.90 | 0.49 | - | - |
| Operating Margin (%) | 6.0% | 13.0% | 6.0% | 12.0% | 10.0% | - | - |
ZIMLAB Share Price Trend — 1-Year Movement Across Quarterly Results
Zim Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices.
Revenue Trend (₹ Cr)
Dec 2025
110
Jun 2025
73
Mar 2025
110
Sept 2025
91
Net Profit Trend (₹ Cr)
Dec 2025
4
Jun 2025
-2
Mar 2025
5
Sept 2025
0
Operating Margin Trend (%)
Dec 2025
12.0%
Jun 2025
6.0%
Mar 2025
13.0%
Sept 2025
6.0%
ZIMLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Zim Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹415,924.72 Cr | 1808.3 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.1 |
|
Divis Laboratories
Sept 2025 |
₹171,625.44 Cr | 6502.5 | 2,860 | 689 | +7.1% | - | 24.1% | 250.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹142,059.09 Cr | 4185.1 | 3,219 | 591 | +11.3% | - | 18.4% | 238.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,348.15 Cr | 1322.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.8 |
|
Cipla
Sept 2025 |
₹105,996.98 Cr | 1309.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 78.3 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores